Related Experiment Video
Updated: May 11, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma
Yasunobu Matsuda1, Toshifumi Wakai, Masayuki Kubota
1Department of Medical Technology, Niigata University Graduate School of Health Sciences, Niigata 951-8518, Japan. yasunobu@med.niigata-u.ac.jp
Abstract:
Hepatocellular carcinoma (HCC) is a common malignant disease with poor prognosis. To improve the clinical outcome, early diagnosis of HCC arising from nonviral agents and hepatitis virus is important. Among several etiological factors, mycotoxins defined as carcinogens by the International Agency for Research in Cancer (IARC) might be one of the critical risk factors for nonviral HCC. Aflatoxin B1 is the most well-known carcinogenic mycotoxin for HCC, but the role of the other types of mycotoxin remains unclear. Several studies have reported that a chromatographic separation technique based on high-performance liquid chromatography can successfully detect the concentration of mycotoxins in plasma. Recently, serum level of ochratoxin A (OTA), a widely distributed mycotoxin classified as Group 2B by IARC, was evaluated in HCC patients in Egypt. The results suggested that serum OTA levels might be a good biomarker for HCC. In this article, we review recent studies of OTA, and discuss its possible significance as a biomarker of HCC.
Related Concept Videos
Mutagenicity and Carcinogenicity
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Bioactivation and Tissue Toxicity
Induced Pluripotent Stem Cells
Somatic cells are...
Drug Toxicity: Risk factors
